CVE-2026-2477: IBM watsonx Orchestrate Cartridge authorization bypass in API endpoints

CVE-2026-2477 · Severity: medium · CVSS 6.5 · Published 2026-11-08

IBM watsonx Orchestrate Cartridge is a business automation and integration component for IBM Cloud Pak for Data. The product fails to enforce authorization checks on backend API endpoints, allowing unprivileged users to bypass interface-level access controls and execute administrative functions they should not have permission to perform.

Technologies: IBM watsonx Orchestrate Cartridge for Cloud Pak for Data. Vendors: IBM.

Quick answers

Is CVE-2026-2477 exploited in the wild?
No. Junglewise Threat Intelligence has no report of CVE-2026-2477 being exploited in the wild.
How severe is CVE-2026-2477?
Medium severity, with a CVSS score of 6.5, published 8 November 2026.
Which products and versions are affected?
IBM watsonx Orchestrate Cartridge for Cloud Pak for Data 4.8.4-4.8.5, 5.0.0-5.4.2.
Is there a fix for CVE-2026-2477?
Yes: fixed in 5.4.4. Junglewise finds every place you run it, drafts the upgrade and applies it once you approve.
How is CVE-2026-2477 attacked?
It is attacked over the network.
Am I affected by CVE-2026-2477?
Check whether you run IBM watsonx Orchestrate Cartridge for Cloud Pak for Data at an affected version. Junglewise does that check for you around the clock: connect your code, cloud and domains, and it matches new vulnerabilities like this one against what you actually run and tells you when one reaches you.

How to fix

  • Fixed in: 5.4.4

Technical details

The vulnerability is a missing authorization check (CWE-862) in the backend API layer of watsonx Orchestrate Cartridge. Low-privileged authenticated users can directly invoke administrative API endpoints that lack role-based access control enforcement, bypassing UI-level restrictions. Network-based attack vector with low complexity; requires prior authentication.

Affected products

  • IBM watsonx Orchestrate Cartridge for Cloud Pak for Data 4.8.4-4.8.5, 5.0.0-5.4.2

Timeline

  • 2026-10-23: disclosed
  • 2026-11-08: advisory

References

This page as Markdown. Free to reuse under CC BY 4.0 with a link back.